Moving Forward From Monotherapy in HCCByAnn-Lii Cheng, MDOctober 22nd 2018Ann-Lii Cheng, MD, discusses where the of hepatocellular carcinoma is headed.
Phase III Findings for Lenvatinib in HCCByAnn-Lii Cheng, MDJuly 11th 2017Ann-Lii Cheng, MD, discusses a phase III trial of lenvatinib vs sorafenib in the first-line treatment of patients with unresectable hepatocellular carcinoma.